An experimental Parkinson’s disease drug on its way to AbbVie as part of an $8.7 billion acquisition has met the goals of a pivotal study, setting up the pharmaceutical giant with a drug prospect that ...
Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...
– ALTO-207 (fka CTC-501) is a fixed-dose combination of pramipexole and ondansetron designed to induce rapid antidepressant effects while mitigating dose-limiting adverse events of pramipexole – – ...
KDKA-AM Radio Pittsburgh on MSN
Women claim their prescription drugs led to risky sexual behavior
Women who were prescribed medication to deal with a neurological disorder that impacts one in 10 Americans have said that the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback